Patent · US Active

Modulators

US11261247B2 · kind B2 · utility

0Cited by
43References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 14, 2018
Grant dateMar 1, 2022
Priority date—
Expiry dateJan 25, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Antibodies that modulate insulin receptor signaling are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.